These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36215342)

  • 21. The detection of the epidemic phase of COVID-19 and the timing of social distancing policies in Korea.
    Kim W
    Public Health; 2021 Dec; 201():89-97. PubMed ID: 34798328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Simulation of a COVID-19 Epidemic Based on a Deterministic SEIR Model.
    Carcione JM; Santos JE; Bagaini C; Ba J
    Front Public Health; 2020; 8():230. PubMed ID: 32574303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the Transmissibility Change of 2019-Novel Coronavirus Pneumonia and Its Potential Factors in China from 2019 to 2020.
    Zhao Y; Wang R; Li J; Zhang Y; Yang H; Zhao Y
    Biomed Res Int; 2020; 2020():3842470. PubMed ID: 32461981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of the reproduction number from coronavirus SARS-CoV-2 case data in Germany and implications for political measures.
    Khailaie S; Mitra T; Bandyopadhyay A; Schips M; Mascheroni P; Vanella P; Lange B; Binder SC; Meyer-Hermann M
    BMC Med; 2021 Jan; 19(1):32. PubMed ID: 33504336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using a latent Hawkes process for epidemiological modelling.
    Lamprinakou S; Gandy A; McCoy E
    PLoS One; 2023; 18(3):e0281370. PubMed ID: 36857340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A versatile web app for identifying the drivers of COVID-19 epidemics.
    Getz WM; Salter R; Luisa Vissat L; Horvitz N
    J Transl Med; 2021 Mar; 19(1):109. PubMed ID: 33726787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Semiparametric Bayesian inference for the transmission dynamics of COVID-19 with a state-space model.
    Zhou T; Ji Y
    Contemp Clin Trials; 2020 Oct; 97():106146. PubMed ID: 32947047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An assessment of transmission dynamics via time-varying reproduction number of the second wave of the COVID-19 epidemic in Fiji.
    Lal R; Huang W; Li Z; Prasad S
    R Soc Open Sci; 2022 Aug; 9(8):220004. PubMed ID: 36061527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in how interventions coupled with effective reproduction numbers account for marked variations in COVID-19 epidemic outcomes.
    Xia F; Xiao Y; Liu PY; Cheke RA; Li XY
    Math Biosci Eng; 2020 Jul; 17(5):5085-5098. PubMed ID: 33120541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positivity rate: an indicator for the spread of COVID-19.
    Al Dallal A; AlDallal U; Al Dallal J
    Curr Med Res Opin; 2021 Dec; 37(12):2067-2076. PubMed ID: 34517740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Assessment of Importation and Local Transmission of COVID-19 in South Korea: Statistical Modeling Approach.
    Lee H; Kim Y; Kim E; Lee S
    JMIR Public Health Surveill; 2021 Jun; 7(6):e26784. PubMed ID: 33819165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spatiotemporal reproduction number with Bayesian model selection for evaluation of emerging infectious disease transmissibility: an application to COVID-19 national surveillance data.
    Rotejanaprasert C; Lawson AB; Maude RJ
    BMC Med Res Methodol; 2023 Mar; 23(1):62. PubMed ID: 36915077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating the time-dependent effective reproduction number and vaccination rate for COVID-19 in the USA and India.
    Bugalia S; Tripathi JP; Wang H
    Math Biosci Eng; 2023 Jan; 20(3):4673-4689. PubMed ID: 36896517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling the COVID-19 Epidemic With Multi-Population and Control Strategies in the United States.
    Sun D; Long X; Liu J
    Front Public Health; 2021; 9():751940. PubMed ID: 35047470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved estimation of time-varying reproduction numbers at low case incidence and between epidemic waves.
    Parag KV
    PLoS Comput Biol; 2021 Sep; 17(9):e1009347. PubMed ID: 34492011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Comparative Analysis of Statistical Methods to Estimate the Reproduction Number in Emerging Epidemics, With Implications for the Current Coronavirus Disease 2019 (COVID-19) Pandemic.
    O'Driscoll M; Harry C; Donnelly CA; Cori A; Dorigatti I
    Clin Infect Dis; 2021 Jul; 73(1):e215-e223. PubMed ID: 33079987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province.
    Wan H; Cui JA; Yang GJ
    Infect Dis Poverty; 2020 Aug; 9(1):116. PubMed ID: 32831142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Who is the infector? Epidemic models with symptomatic and asymptomatic cases.
    Leung KY; Trapman P; Britton T
    Math Biosci; 2018 Jul; 301():190-198. PubMed ID: 29654792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Model-Based Evaluation of Transmissibility and Intervention Measures for a COVID-19 Outbreak in Xiamen City, China.
    Liu W; Guo Z; Abudunaibi B; Ouyang X; Wang D; Yang T; Deng B; Huang J; Zhao B; Su Y; Su C; Chen T
    Front Public Health; 2022; 10():887146. PubMed ID: 35910883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.